Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | STAT3 | P40763 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29831982 | 0.86 | ALDH1A1 (0.50) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL68891 | 0.83 | KDM4E (0.51) | KDM4EALDH1A1HPGDALOX15HTT | |
| SCHEMBL8905796 | 0.83 | TDP1 (0.47) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL3841616 | 0.83 | ALDH1A1 (0.47) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL8630313 | 0.83 | KDM4E (0.51) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL30288437 | 0.83 | KDM4E (0.51) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL2422281 | 0.83 | ALDH1A1 (0.47) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL8627406 | 0.82 | TLR8 (0.54) | KDM4EALDH1A1HPGDALOX15HTT | |
| SCHEMBL30693766 | 0.82 | KDM4E (0.50) | KDM4EALDH1A1HPGDALOX15HTT | |
| SCHEMBL3364626 | 0.82 | TLR8 (0.46) | KDM4EALDH1A1HPGDGAAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240376154-A1 | BIS-INTERCALATING PEPTIDES, CONJUGATES AND METHODS OF USE | ZYMEWORKS BC INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| US-8748388-B2 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2014-06-10 | — | — | US | disclosed |
| EP-1343516-A4 | ANALOGUES OF THIOCORALINE AND BE-22179 | SCRIPPS RESEARCH INST (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040072738-A1 | Analogues of thiocoraline and be-22179 | SCRIPPS RESEARCH INSTITUTE, THE | 2004-04-15 | — | — | US | disclosed |
| EP-1343516-A2 | ANALOGUES OF THIOCORALINE AND BE-22179 | The Scripps Research Institute (US) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002049577-A2 | ANALOGUES OF THIOCORALINE AND BE-22179 | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-06-27 | — | — | WO | disclosed |
| US-6329497-B1 | ANTITUMOR AGENTS; VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS | THE SCRIPPS RESEARCH INSTITUTE | 2001-12-11 | — | — | US | disclosed |
| EP-0996458-A4 | SANDRAMYCIN ANALOGS | SCRIPPS RESEARCH INST (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-0996458-A1 | SANDRAMYCIN ANALOGS | The Scripps Research Institute (US) | 2000-05-03 | — | — | EP | disclosed |
| WO-1998043663-A1 | SANDRAMYCIN ANALOGS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240376154-A1 | BIS-INTERCALATING PEPTIDES, CONJUGATES AND METHODS OF USE | PCNA, POLI, VIP | KDM4E 4594/4885ALDH1A1 3388/4885HPGD 4117/4885 |
| US-20040072738-A1 | Analogues of thiocoraline and be-22179 | SSBP1, TOP2B, TOP1 | KDM4E 3356/4885ALDH1A1 3103/4885HPGD 3214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.